MedTrace Logo

Older Emergency Department Users and Short-term Adverse Events at the Index Visit

NCT04018898 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 10971

Last updated 2024-07-23

No results posted yet for this study

Summary

This study evaluates the difference between PRISMA-7 and ER2 tool. There are some differences between PRISMA-7 and ER2 tool. The differences consist in evaluation criteria that are used to perform the both surveys. We suppose that evaluation criteria of PRISMA-7 is not accurately enough to calculate the length of hospital stay and to predict the short-term outcomes.

Conditions

  • Health Impairment
  • Adverse Event
  • Hospitalization

Sponsors & Collaborators

  • Jewish General Hospital

    lead OTHER

Principal Investigators

  • Oliver Beauchet, MD · Jewish General Hospital

Eligibility

Min Age
75 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2019-07-23
Primary Completion
2024-03-01
Completion
2024-07-01

Countries

  • Canada

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04018898 on ClinicalTrials.gov